Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Biomarkc posts improvement in Phase 2 Study in Non Small Cell Lung Cancer
July 10, 2019 Off

Biomarkc posts improvement in Phase 2 Study in Non Small Cell Lung Cancer

By Dino Mustafić

Biomarck Pharmaceuticals has improved the Overall Response Rate (ORR) in the BIO-11006/SOC group compared to standard of care alone at 3 months in the Phase 2 study in NSCLC, which compares standard of care alone, to SOC plus BIO-11006 in 60 patients with stage 4.

Dr. Reddy’s to release Q1 FY 20 results on July 29, 2019
July 10, 2019 Off

Dr. Reddy’s to release Q1 FY 20 results on July 29, 2019

By BusinessWire

Earnings call slated for July 29, 6:30 PM IST / 9:00 AM EDT HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE:…

July 10, 2019 Off

Point-of-Care Diagnostics and Technologies Take Center Stage at Next Generation Dx Summit, August 20-22 in Washington, DC

By BusinessWire

800 Leaders Unite to Advance Rapid Diagnostics Opening New Frontiers in Precision Medicine WASHINGTON–(BUSINESS WIRE)–#Biomarkers–Responding to the growth of the…

Trovagene enrolls patients to further test certain cancer treatment combo
July 10, 2019 Off

Trovagene enrolls patients to further test certain cancer treatment combo

By Dino Mustafić

Trovagene has started erolling patients for its second phase study of onvansertib plus FOLFIRI and Avastin (bevacizumab) for second-line treatment of patients with metastatic colorectal cancer (mCRC) with a KRAS mutation.

BioNTech Raises $325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline
July 10, 2019 Off

BioNTech Raises $325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline

By BusinessWire

BioNTech pulled one of the largest private EU biotech funding events expands global shareholder base with $325 from investors

Takeda Continues Ongoing Inclusion in the FTSE4Good Developed Index & MSCI ESG Leaders Index
July 10, 2019 Off

Takeda Continues Ongoing Inclusion in the FTSE4Good Developed Index & MSCI ESG Leaders Index

By BusinessWire

– Selected by the FTSE4Good Developed Index for the 15th consecutive year – Named to the MSCI ESG Leaders Index…

July 10, 2019 Off

Teva to Present New Data on AJOVY® (fremanezumab-vfrm) Injection at the American Headache Society’s 61st Annual Scientific Meeting

By BusinessWire

Three late breakers, one oral presentation and 27 posters showcase AJOVY as a preventive treatment for migraine JERUSALEM & PARSIPPANY,…

July 10, 2019 Off

Research Collaboration Between U-M and Atomwise to Accelerate Drug Discovery Using Innovative Artificial Intelligence Approach

By BusinessWire

ANN ARBOR, Mich.–(BUSINESS WIRE)–#AI–From making pain management safer and more effective to identifying inhibitors for a fibrosis target protein and…

July 10, 2019 Off

Ligand Announces Positive Top Line Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol

By BusinessWire

Study achieved primary endpoint demonstrating pharmacokinetic bioequivalence between Captisol-enabled Iohexol and OMNIPAQUE™ SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today…

July 10, 2019 Off

First U.S. Patient Receives GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL

By BusinessWire

Data shows 100% successful deployment and no fractures at 30-day follow-up in European Registry FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore &…

Posts pagination

Previous 1 … 3,015 3,016 3,017 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine